Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
China · Delayed Price · Currency is CNY 6.80
-0.01 (-0.15%)
Sep 30, 2025, 3:00 PM CST
SHA:603718 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 174.29 | 171.18 | 62.87 | 121.61 | 53.86 | 8.93 | Upgrade |
Depreciation & Amortization | 28.04 | 37.37 | 39.71 | 47.37 | 57.57 | 58.22 | Upgrade |
Other Amortization | 1.94 | 1.89 | 1.16 | 2.27 | 3.9 | 9.46 | Upgrade |
Loss (Gain) From Sale of Assets | -0.22 | - | -0.61 | 0.36 | -7.41 | -0.03 | Upgrade |
Asset Writedown & Restructuring Costs | 1.9 | 1.89 | 0.05 | 0.14 | - | 5.24 | Upgrade |
Loss (Gain) From Sale of Investments | -143.55 | -145.64 | -56.62 | -11.44 | -35.89 | -25.09 | Upgrade |
Provision & Write-off of Bad Debts | 4.76 | 3.94 | 1.03 | -0.43 | 4.95 | 6.27 | Upgrade |
Other Operating Activities | 25.26 | 8.17 | -4.17 | -0.53 | 10.43 | -23.3 | Upgrade |
Change in Accounts Receivable | -3.36 | -19.41 | 54.92 | 24.66 | -68.69 | 11.71 | Upgrade |
Change in Inventory | 2.41 | 9.17 | 5.76 | -3.79 | -30.32 | -1.56 | Upgrade |
Change in Accounts Payable | -50.9 | -59.21 | -129.71 | 117.43 | 54.76 | 117.94 | Upgrade |
Change in Other Net Operating Assets | 20.45 | 20.45 | 23.29 | - | - | - | Upgrade |
Operating Cash Flow | 72.93 | 46.47 | -8.37 | 292.91 | 43.63 | 167.68 | Upgrade |
Operating Cash Flow Growth | 53.19% | - | - | 571.29% | -73.98% | 183.00% | Upgrade |
Capital Expenditures | -8.79 | -8.39 | -7.81 | -19.85 | -37.78 | -34.12 | Upgrade |
Sale of Property, Plant & Equipment | 0.31 | - | 0.08 | 0.15 | 28.21 | 3.11 | Upgrade |
Cash Acquisitions | -789.84 | -768.33 | -2.29 | - | -31.5 | -42 | Upgrade |
Divestitures | -9.83 | -9.83 | 110.98 | - | - | - | Upgrade |
Investment in Securities | 694.09 | 625.23 | -277.49 | 74.62 | 63.99 | -174.07 | Upgrade |
Other Investing Activities | 199.53 | 199.66 | 5.43 | 11.2 | 18.62 | 21.24 | Upgrade |
Investing Cash Flow | 85.46 | 38.34 | -171.09 | 66.13 | 41.54 | -225.84 | Upgrade |
Short-Term Debt Issued | - | 837.99 | 200 | 20 | 18 | 22.8 | Upgrade |
Total Debt Issued | 802.99 | 837.99 | 200 | 20 | 18 | 22.8 | Upgrade |
Short-Term Debt Repaid | - | -688.41 | -66.48 | -368.32 | -23.81 | - | Upgrade |
Long-Term Debt Repaid | - | -1.71 | -2.07 | -6.53 | -1.2 | - | Upgrade |
Total Debt Repaid | -618.48 | -690.13 | -68.55 | -374.85 | -25.01 | - | Upgrade |
Net Debt Issued (Repaid) | 184.51 | 147.86 | 131.45 | -354.85 | -7.01 | 22.8 | Upgrade |
Issuance of Common Stock | - | - | 66.44 | - | - | - | Upgrade |
Common Dividends Paid | -20.69 | -21.57 | -37.9 | -0.68 | -2.98 | -3.86 | Upgrade |
Other Financing Activities | - | - | - | - | 60 | 6.11 | Upgrade |
Financing Cash Flow | 153.07 | 126.29 | 159.99 | -355.53 | 50.01 | 25.04 | Upgrade |
Foreign Exchange Rate Adjustments | 9.6 | 10.3 | 0 | 0.01 | -0 | -0.02 | Upgrade |
Net Cash Flow | 321.05 | 221.41 | -19.46 | 3.52 | 135.18 | -33.14 | Upgrade |
Free Cash Flow | 64.14 | 38.08 | -16.18 | 273.06 | 5.85 | 133.56 | Upgrade |
Free Cash Flow Growth | 67.67% | - | - | 4564.07% | -95.62% | 560.41% | Upgrade |
Free Cash Flow Margin | 23.48% | 14.05% | -6.72% | 91.02% | 1.69% | 51.54% | Upgrade |
Free Cash Flow Per Share | 0.10 | 0.06 | -0.03 | 0.43 | 0.01 | 0.15 | Upgrade |
Cash Income Tax Paid | 38.61 | 23.89 | 57.7 | 16.19 | 28.94 | 19.41 | Upgrade |
Levered Free Cash Flow | 26.56 | 44.68 | 80.42 | 180.23 | -163.6 | -51.54 | Upgrade |
Unlevered Free Cash Flow | 28.85 | 48.11 | 83.79 | 186.68 | -155.87 | -40.49 | Upgrade |
Change in Working Capital | -19.49 | -32.33 | -51.78 | 133.55 | -43.76 | 127.98 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.